Mometason Abece (Mometasone Furoate)

Mometasone Furoate, the active ingredient in Mometason Abece, is a corticosteroid presented as a nasal spray for nasal use. It reduces inflammation of the nasal mucosa and is indicated for the treatment of seasonal and perennial allergic rhinitis and for managing nasal polyps in adults and children.

GNH USA supplies Mometason Abece as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Mometasone furoate nasal spray is employed to manage inflammatory conditions of the nasal passages, primarily within the allergic rhinitis pathway.

Allergic rhinitis: relief of nasal congestion, itching, sneezing and rhinorrhea in seasonal or perennial allergy sufferers. Nasal polyps: reduction of polyp size and improvement of nasal airflow. Post‑operative nasal inflammation: helps to decrease swelling and promote healing after sinus surgery. Seasonal allergic rhinitis: control of symptoms during pollen exposure periods. Perennial allergic rhinitis: ongoing symptom management for year‑round allergens.

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Headache. - Epistaxis (nosebleeds). - Throat irritation or dryness. - Altered taste or unpleasant taste.

Serious or Rare Side Effects: - Nasal septal perforation. - Severe or persistent epistaxis. - Vision changes or cataract formation. - Adrenal suppression with prolonged high‑dose use. - Opportunistic fungal infection of the nasal passages.

Before using Mometason Abece, consider the following safety measures.

Pediatric use: follow prescriber guidance for age‑appropriate dosing. Prolonged therapy: limit duration unless medically supervised. Signs of infection: discontinue and seek medical advice if fungal or bacterial infection develops. Glaucoma or cataract: monitor intra‑ocular pressure regularly. Concurrent nasal decongestants: avoid simultaneous use to reduce risk of mucosal damage. Store at room temperature: keep in original container, protect from moisture and direct heat.

Mometasone furoate nasal spray can interact with other medications; awareness of these interactions helps ensure safe use.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug exposure. - Immunosuppressants: heightened potential for infections.

Moderate Interactions (Monitor Closely): - Antihistamines: may augment sedative effects when combined with certain agents. - Nasal decongestant sprays: risk of rebound congestion if used together.